Related Experiment Videos
Pancreas transplantation from marginal donors
U Boggi1, M Del Chiaro, F Vistoli
1Divisione di Chirurgia Generale e Trapianti, Università di Pisa, Pisa, Italy.
Transplantation Proceedings
|April 28, 2004
Summary
Marginal donor organs can be safely used for pancreas transplantation (PTx), expanding the donor pool. This study found comparable outcomes for pancreas transplants from marginal donors versus non-marginal donors.
Area of Science:
- Transplantation immunology
- Organ procurement
- Surgical outcomes
Background:
- Marginal donor organs offer a largely untapped resource for increasing the availability of grafts for pancreas transplantation (PTx).
- Optimizing the use of marginal donor organs is crucial for expanding transplant options.
Purpose of the Study:
- To evaluate the safety and efficacy of using marginal donor (MD) organs for pancreas transplantation.
- To compare outcomes of PTx using marginal donor grafts versus non-marginal donor (NMD) grafts.
Main Methods:
- A retrospective analysis of 100 pancreas transplants was conducted.
- Grafts were categorized as either non-marginal (NMD) or marginal (MD) based on donor age (>45 years) and/or hemodynamic instability.
- Outcomes assessed included delayed endocrine pancreas function (DEPF), complication rates, and patient/graft survival.
Main Results:
- No significant difference in the incidence of delayed endocrine pancreas function (DEPF) between NMD (6.2%) and MD (0%) groups (P >.05).
- Similar complication rates were observed: relaparotomy rates were 12.5% for NMD and 9.6% for MD (P >.05).
- One-year actuarial graft survival was high for both groups (91.7% for NMD, 94.2% for MD) with comparable patient survival rates (97.9% for NMD, 98.1% for MD).
Conclusions:
- Pancreas grafts from marginal donors can be safely utilized in PTx.
- Employing marginal donor organs significantly expands the potential donor pool for pancreas transplantation, improving access to this life-saving procedure.